Global Proteomics Analysis of Circulating Extracellular Vesicles Isolated from Lung Transplant Recipients
journal contributionposted on 12.06.2020, 18:34 by Sandhya Bansal, Marissa McGilvrey, Krystine Garcia-Mansfield, Ritin Sharma, Ross M. Bremner, Michael A. Smith, Ramsey Hachem, Patrick Pirrotte, Thalachallour Mohanakumar
Lung transplant recipients (LTxRs) with acute rejection (AR) and chronic rejection (bronchiolitis obliterans syndrome [BOS]) induce circulating exosomes known to contain donor human leukocyte antigens and lung-associated self-antigens. Here, we sought to identify proteomic signatures in circulating extracellular vesicles (EVs) that differentiate LTxRs in 4 groups: stable, AR, BOS, or respiratory viral infection (RVI). EVs were isolated from plasma from patients in each group via ultracentrifugation. EV protein cargoes were prepared for shotgun proteomics using liquid chromatography–tandem mass spectrometry. We identified 2 unique proteins for AR, 4 for RVI, 24 for BOS, and 8 for stable LTxRs. Differential analysis of AR, BOS, RVI, and stable proteins identified significantly deregulated proteins (p < 0.05, log2(fold change) > ±1) in each condition (31, 2, and 2, respectively). EVs from LTxRs with AR contained proteins involved in immunoglobulin, complement regulation, coagulation, and innate and adaptive immune response pathways. EVs from LTxRs with BOS revealed enriched immunoglobulin receptors and a carboxypeptidase N catalytic chain. EVs from LTxRs with RVI had an enriched macrophage-stimulating factor. We found unique signatures in LTxRs with AR, BOS, and RVI, highlighting complex immune mechanisms underlying lung allograft rejection. Proteomic signatures in LTxRs’ circulating EVs provided insights into immunological mechanisms of graft rejection and RVI.
Read the peer-reviewed publication
shotgun proteomicsBOSCirculating Extracellular VesiclesDifferential analysisRVIresponse pathwaysLTxRextracellular vesiclesmacrophage-stimulating factorProteomic signaturesproteomic signaturesgraft rejectionlung allograft rejectionimmunoglobulin receptorsGlobal Proteomics Analysis4 groupsleukocyte antigenscarboxypeptidase Nbronchiolitis obliterans syndromelung-associated self-antigenscomplement regulationEV protein cargoesLung Transplant Recipients Lung transplant recipientsAR